Apple Shares Face Uncertainty as iPhone 17 Launch Stumbles

Apple’s highly anticipated iPhone 17 launch has encountered significant turbulence, with a critical market delay and key executive departure creating headwinds for the technology giant. These developments emerge just as the company prepares for its crucial holiday sales season, raising questions about its near-term performance.

Regulatory Hurdles Disrupt Chinese Launch Plans

In a substantial setback for Apple’s global rollout strategy, the introduction of the new iPhone Air in China has been unexpectedly postponed. The company announced that “release information will be updated at a later date” shortly after global pre-orders commenced on Friday. This delay stems from regulatory challenges concerning the device’s eSIM technology within the Chinese market. The timing presents particular concern for investors, as the postponement in one of Apple’s most profitable markets coincides with the beginning of the critical holiday shopping period.

Mixed Developments: Regulatory Win Offsets by AI Departure

Friday brought both positive and negative developments for the Cupertino-based company. While facing challenges in China, Apple received the long-awaited FDA clearance for a new hypertension detection system designed for the Apple Watch. The health feature is scheduled to become available in 150 countries starting next week, marking a significant advancement in the company’s strategy to expand its wearables division.

This regulatory achievement was quickly overshadowed by personnel news from Apple’s artificial intelligence division. Robby Walker, a Senior Director within the AI team, has decided to leave the company. His departure has intensified investor concerns regarding Apple’s competitive positioning in the rapidly evolving artificial intelligence landscape.

Should investors sell immediately? Or is it worth buying Apple?

Growing Analyst Skepticism

Recent events appear to validate a growing trend among Wall Street analysts: confidence in Apple shares has declined to its lowest point in five years. Currently, only 55 percent of analysts recommend buying the stock. Investment firm D.A. Davidson downgraded Apple to “Neutral” this week, citing an “uninspired” product lineup that fails to address ongoing doubts about the company’s artificial intelligence roadmap.

This increasing caution contrasts with what has otherwise been a promising pre-order period for the iPhone 17 series. Although the new models will become widely available starting September 19th, the uncertain situation in China continues to pose a significant risk to the company’s upcoming quarterly results.

Critical Timeline Ahead

Market attention now focuses on two imminent events: the scheduled release of iOS 26 on Monday, followed by the official retail launch of the new iPhones on Friday. Initial sales figures and potential developments regarding Chinese regulatory approval will provide crucial indicators for determining whether Apple’s current challenges represent temporary obstacles or more persistent structural issues.